Skip to main content
Premium Trial:

Request an Annual Quote

Eagle Genomics, Open PHACTS to Link Genomics Software, Data with Drug Information


Eagle Genomics said last week that it will work with members of the European Union's Open PHACTS consortium to link the Open PHACTS platform with genomics tools and workflows such as Galaxy as well as to integrate information from reference databases such as Ensembl.

Open PHACTS, short for Open Pharmacological Triple Store, is building a free semantic data integration platform called the Open Pharmacological Space that will allow scientists to explore integrated biological and chemical data.

The OPS platform will attach factual assertions extracted as semantic triples to scientific text. This should make it possible for users to query textual and database information together and identify new drug targets and pharmacological interactions.

Open PHACTS is funded by the European Commission's Innovative Medicine Initiative. The three-year project kicked off in January 2011 with €10 million ($12 million) in IMI funding, €4 million in in-kind funding from the European Federation of Pharmaceutical Industries and Associations, and €2.2 million in funding from other sources.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.